Molecularly imprinted therapeutic contact lenses

Bibliography

• Wichterle O, Lim D. Cross-linked hydrophilic polymers and articles made therefrom. US patent: 3220960; 1965
   Google Scholar
• Wichterle O, Lim D. Hydrophilic gels for biological use. Nature 1960;185:117-8
   Web of Science ®Google Scholar
• Wichterle O, Lim D. Process for producing shaped articles from three-dimensional hydrophilic high polymer. US patent: 2976576; 1961
   Google Scholar
• Sedlavek J. Possibilities of application of eye drugs with the aid of gel-contact lenses. Cesk Slov Oftalmol 1965;21:509-12
   Google Scholar
• Arrington G. A history of ophthalmology. MD Publications, New York; 1959
   Google Scholar
• Albert D. History of ophthalmology. Blackwell Sciences, Inc., Cambridge; 1996
   Google Scholar
• Hirchberg R. The history of ophthalmology. Volume 1. Antiquity. Translated by Frederick Blodi. Kugler Publications, Bonn; 1982
   Google Scholar
• Karlgard C, Wong N, Jones L, Moresoli C. In vitro uptake and release studies of ocular pharmaceutical agents by silicon-containing and p-HEMA hydrogel contact lens materials. Int J Pharm 2003;257:141-51
   PubMed Web of Science ®Google Scholar
• Kapoor Y, Thomas J, Tan G, Surfactant laden soft contact lenses for extended delivery of ophthalmic drugs. Biomaterials 2009;30:867-78
   PubMed Web of Science ®Google Scholar
• Li C, Abrahamson M, Kapoor Y, Chauhan A. Timolol transport from microemulsions trapped in HEMA gels. J Colloid Interface Sci 2007;315:297-306
   PubMed Web of Science ®Google Scholar
• Gulsen D, Li C, Chauhan A. Dispersion of DPMC liposomes in contact lenses for ophthalmic drugs. Curr Eye Res 2005;30(12):1071-80
   PubMed Web of Science ®Google Scholar
• Gulsen D, Chauhan A. Ophthalmic drug delivery through contact lenses. Invest Ophthalmol Vis Sci 2004;45:2342-7
   PubMed Web of Science ®Google Scholar
• Uchida R, Sato T, Tanigawa H, Uno K. Azulene incorporation and release by hydrogel containing methacrylamide propyltrimethylammonium chloride and its application to soft contact lens. J Control Release 2003;92(3):259-64
   PubMed Web of Science ®Google Scholar
• Sato T, Uchida R, Tanigawa H, Application of polymer gels containing side-chain phosphate groups to drug-delivery contact lenses. J Control Release 2003;92(3):259-64
   PubMedGoogle Scholar
• Byrne M, Salian V. Molecular imprinting within hydrogels II: progress and analysis of the field. Int J Pharm 2008;364(2):188-212
   PubMedGoogle Scholar
• Byrne M, Park K, Peppas N. Molecular imprinting within hydrogels. Adv Drug Deliv Rev 2002;54(1):149-61
   PubMed Web of Science ®Google Scholar
• Ali M, Byrne M. Challenges and solutions in topical ocular drug-delivery systems. Expert Rev Clin Pharmacol 2008;1(1):145-61
   PubMedGoogle Scholar
• Vandamme TF. Microemulsions as ocular drug delivery systems: recent developments and future challenges. Prog Retin Eye Res 2002;21:15-34
   PubMed Web of Science ®Google Scholar
• Zurowska-Pryczkowska K, Sznitsowska M, Janicki S. Studies on the effect of pilocarpine incorporation into a submicron emulsion on the stability of the drug and the vehicle. Eur J Pharm Biopharm 1999;47(3):255-60
   PubMed Web of Science ®Google Scholar
• Naveh N, Muchtar A, Benita S. Pilocarpine incorporated into a submicron emulsion vehicle causes an unexpectedly prolonged ocular hypotensive effect in rabbits. J Ocul Pharmacol 1994;10(3):15-34
   Google Scholar
• Fialho S, da Silva-Cunha A. New vehicle based on a microemulsion for topical ocular administration of dexamethasone. Clin Exp Ophthalmol 2004;32(6):626-32
   PubMed Web of Science ®Google Scholar
• Zimmer A, Kreuter J. Microspheres and nanoparticles used in ocular delivery systems. Adv Drug Deliv Rev 1995;16:61-73
   Web of Science ®Google Scholar
• Mainardes R, Urban M, Cinto P, Colloidal carriers for ophthalmic drug delivery. Curr Drug Targets 2005;6(3):363-71
   PubMed Web of Science ®Google Scholar
• Pignatello R, Bucolo C, Ferrara P, RS100® Nanosuspensions for the ophthalmic conrolled delivery of ibuprofen. Eur J Pharm Sci 2002;16(1-2):53-61
   PubMed Web of Science ®Google Scholar
• Kassem M, Abdel Rahman A, Ghorab M, Nanosuspension as an ophthalmic delivery systems for certain glucocorticoid drugs. Int J Pharm 2007;340(1-2):126-33
   PubMedGoogle Scholar
• Ebrahim S, Peyman G, Lee P. Applications of liposomes in ophthalmology. Surv Ophthalmol 2005;50(2):167-82
   PubMed Web of Science ®Google Scholar
• Ticho U, Blumenthal M, Zonis S, Piloplex, a new long acting pilocarpine polymer salt. A: long-term study. Br J Ophthalmol 1979;63:45-7
   PubMed Web of Science ®Google Scholar
• Mazor Z, Ticho U, Rehany U, Rose L. Piloplex, a new long acting pilocarpine polymer salt. B: comparative study of the visual effects of pilocarpine and piloplex eye drops. Br J Ophthalmol 1979;63:58-61
   Google Scholar
• Maurice D. Prolonged-action drops. Int Ophthalmol Clin 1993;33:81-91
   PubMedGoogle Scholar
• Bernkop-Schnerch A. Thiomers: a new generation of mucoadhesive polymers. Adv Drug Deliv Rev 2005;57(11):1569-82
   PubMed Web of Science ®Google Scholar
• Hornof M, Weyenberg W, Ludwig A, Bernkop-Schnurch A. Mucoadhesive ocular insert based on thiolated poly(acrylic acid): development and in vivo evaluation in humans. J Control Release 2003;89(3):419-28
   PubMed Web of Science ®Google Scholar
• Aggarwal D, Kaur I. Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system. Int J Pharmacol 2005;290(1-2):155-9
   Google Scholar
• Greaves J, Wilson C. Treatment of diseases of the eye with mucoadhesive delivery systems. Adv Drug Deliv Rev 1993;11(3):349-83
   Web of Science ®Google Scholar
• Ludwig A. The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev 2005:57(11):1595-639
   PubMed Web of Science ®Google Scholar
• Lin H, Sung K. Carbopol/pluronic phase change solution for ophthalmic drug delivery. J Control Release 2000;69:379-88
   PubMed Web of Science ®Google Scholar
• Sultana Y, Aqil M, Ali A, Zafar S. Evaluation of carbopol-methyl cellulose based sustained-release ocular delivery system for pefloxacin mesylate using rabbit eye model. Pharm Dev Technol 2006;11(3):313-19
   PubMed Web of Science ®Google Scholar
• Rozier A, Mazuel C, Grove J, Plazonnet B. Gelrite®: a novel, ion-activated, in-situ gelling polymer for ophthalmic vehicles. Effect on bioavailability of timolol. Int J Pharmacol 1989;57(2):163-8
   Google Scholar
• Sultana Y, Aqil M, Ali A. Ion-activated Gelrite®-based in situ ophthalmic gels of perfloxacin mesylate: comparison with conventional eye drops. Drug Deliv 2006;13(3):215-19
   PubMed Web of Science ®Google Scholar
• Tai M, Cosar C, Cohen E, Clinical efficacy of silicone punctal plug therapy. Cornea 2002;21(2):135-39
   PubMed Web of Science ®Google Scholar
• Balaram M, Schaumberg D, Dana M. Efficacy and tolerability outcomes after punctal occlusion with silicone plugs in dry eye syndrome. Am J Ophthalmol 2001;131(1):30-6
   PubMed Web of Science ®Google Scholar
• Willis RM, Folberg R, Krachmer JH, Holland EJ. Treatment of aqueous-deficient dry eye with removable punctal plugs. A clinical and impression-cytologic study. Ophthalmology 1987;94(5):514-8
   PubMed Web of Science ®Google Scholar
• Lang J. Ocular drug delivery: conventional ocular formulations. Adv Drug Deliv Rev 1995;16(1):39-43
   Web of Science ®Google Scholar
• Geroski D, Edelhauser H. Drug delivery for posterior segment eye disease. Invest Ophthalmol Vis Sci 2000;41(5):961-4
   PubMed Web of Science ®Google Scholar
• Clark A, Yorio T. Ophthalmic drug discovery. Nat Rev Drug Discov 2003;2(6):446-59
   Google Scholar
• Ghate D, Edelhauser H. Ocular drug delivery. Expert Opin Drug Deliv 2006;3(2):275-87
   PubMedGoogle Scholar
• Le Bourlais C, Acar L, Zia H, Ophthalmic drug delivery systems: recent advances. Prog Retin Eye Res 1998;1:33-58
   Google Scholar
• Saettone M. Progress and problems in ophthalmic drug delivery. Pharmatech 2002:1-6
   Google Scholar
• Schoenwald R. Ocular pharmacokinetics. In: Zimmerman T, Kooner K, Sharir M, , editors, Textbook of ocular pharmacology. Lippincott-Raven Publishers, Pennsylvania; 1997. p. 119-39
   Google Scholar
• Bartlett J, Jaanus S. Clinical ocular pharmacology. Butterworth-Heinemann Publishers, Massachusetts; 1984
   Google Scholar
• Glasson M, Stapleton F, Keay L, Willcox M. The effect of short term contact lens wear on the tear film and ocular surface characteristics of tolerant and intolerant wearers. Contact Lens Anterior Eye 2006;29(1):41-7
   PubMedGoogle Scholar
• Doane M. Blinking and the mechanics of the lacrimal drainage system. Ophthalmology 1981;88(8):844-51
   PubMed Web of Science ®Google Scholar
• Sharma A, Ruckenstein E. Mechanism of tear film rupture and its implications for contact lens tolerance. Am J Optom Physiol Opt 1985;62(2):246-53
   PubMedGoogle Scholar
• Sklubalova Z, Zatloukal Z. Systemic study of factors affecting eye drop size and dosing variability. Pharmazie 2005;60(12):917-21
   PubMed Web of Science ®Google Scholar
• Peppas N. Hydrogels in medicine and pharmacy. Volume I: Fundamentals. CRC Press, Boca Raton; 1987
   Google Scholar
• Hilt J, Byrne M. Configurational biomimiesis in drug delivery: molecular imprinting of biologically significant molecules. Adv Drug Deliv Rev 2004;56:1599-620
   PubMed Web of Science ®Google Scholar
• Ge Y, Turner A. Too large to fit? Recent developments in macromolecular imprinting. Trends Biotechnol 2008;29:89-104
   Google Scholar
• Hillberg A, Tabrizian M. Biomolecule imprinting: developments in mimicking dynamic natural recognition systems. ITBM RBM 2008;29:89-104
   Google Scholar
• Bergmann N, Peppas N. Molecularly imprinted polymers with specific recognition for macromolecules and proteins. Prog Polym Sci 2008;33:271-88
   Web of Science ®Google Scholar
• Wei S, Jakusch M, Mizaikoff B. Capturing molecules with templated materials – analysis and rational design of molecularly imprinted polymers. Anal Chim Acta 2006;578:50-8
   PubMed Web of Science ®Google Scholar
• Zhang H, Ye L, Mosbach K. Non-covalent molecular imprinting with emphasis on its application in separation and drug development. J Mol Recognit 2006;19:248-59
   PubMed Web of Science ®Google Scholar
• Janiak D, Kofinas P. Molecular imprinting of peptides and proteins in aqueous media. Anal Bioanal Chem 2007;389:399-404
   PubMed Web of Science ®Google Scholar
• Bossi A, Bonini F, Turner A, Piletsky S. Molecularly imprinted polymers for the recognition of proteins: state of the art. Biosens Bioelectron 2007;22(6):1131-7
   Google Scholar
• Turner N, Jeans C, Brain K, From 3D to 2D: a review of the molecular imprinting of proteins. Biotechnol Prog 2006;22(6):1474-89
   Google Scholar
• Ye L, Mosbach K. Molecular imprinting: synthetic materials as substitutes for biological antibodies and receptors. Chem Mater 2008;20:859-68
   Web of Science ®Google Scholar
• Wulff G. Enzyme-like catalysis by molecularly imprinted polymers. Chem Rev 2002;102:1-27
   PubMed Web of Science ®Google Scholar
• Mayes A, Whitecombe M. Synthetic strategies for the generation of molecularly imprinted organic polymers. Adv Drug Deliv Rev 2005;57:1742-78
   PubMed Web of Science ®Google Scholar
• Wei S, Mizaikoff B. Recent advanced on noncovalent molecular imprints for affinity separations. J Sep Sci 2007;30:1794-805
   PubMed Web of Science ®Google Scholar
• Whitcombe M, Vulfson E. Imprinted polymers. Adv Mater 2001;13:467-78
   Web of Science ®Google Scholar
• Alexander C, Andersson H, Andersson L, Molecular imprinting science and technology: a survey of the literature for the years up to and including 2003. J Mol Recognit 2006;19:106-80
   PubMed Web of Science ®Google Scholar
• Davis M, Katz A, Ahmad W. Rational catalyst design via imprinted nanostructured materials. Chem Mater 1996;8:1820-39
   Web of Science ®Google Scholar
• Alvarez-Lorenzo C, Concheiro A. Molecularly imprinted polymers for drug delivery. J Chromatogr B 2004;804:231-45
   PubMed Web of Science ®Google Scholar
• Sellergen B, Allender C. Molecularly imprinted polymers: a bridge to advanced drug delivery. Adv Drug Deliv Rev 2005;57:1733-41
   PubMed Web of Science ®Google Scholar
• Allender C, Richardson C, Woodhouse B, Pharmaceutical applications for molecularly imprinted polymers. Int J Pharmacol 2000;195:39-43
   Google Scholar
• Cunliffe D, Kirby A, Alexander C. Molecularly imprinted drug delivery systems. Adv Drug Deliv Rev 2005;57:1836-53
   PubMed Web of Science ®Google Scholar
• Brazel C, Peppas N. Modeling of drug release from swellable polymers. Eur J Pharm Biopharm 2000;49:47-58
   PubMed Web of Science ®Google Scholar
• Tahara K, Yamato K, Nishihata T. Overall mechanism behind matrix sustained release tablets prepared with hydroxypropyl methylcellulose 2910. J Control Release 1995;35:59-66
   Web of Science ®Google Scholar
• Lee E, Kim S, Cardinal J, Jacobs H. Drug release from hydrogel devices with rate controlling barriers. J Membr Sci 1980;7:293-303
   Web of Science ®Google Scholar
• Lee P. Novel approach to zero order drug delivery via immobilized non-uniform drug distribution in glassy hydrogels. J Pharm Sci 1984;7:1344-7
   Google Scholar
• Alvarez-Lorenzo C, Hiratani H, Concheiro A. Contact lenses for drug delivery: achieving sustained release with novel systems. Am J Drug Deliv 2006;4(3):131-51
   Google Scholar
• Alvarez-Lorenzo C, Hiratani H, Gomez-Amoza JL, Soft contact lenses capable of sustained delivery of timolol. J Pharam Sci 2002;91(10):2182-92
   PubMed Web of Science ®Google Scholar
• Friedman DS, Congdon N, Kempen J, Tielsch JM. Vision Problems in the U.S.: Prevalence of Adult Vision Impairment and Age-Related Eye Disease in America, National Eye Institute and Prevent Blindness America, (2002). Available from: http://www.nei.nih.gov/eyedata/ [Accessed 1 July 2007]
   Google Scholar
• National Eye Inst. Progress in Eye and Vision Research 1999-2006, National Institute of Health, US Department of Health and Human Services; 2006
   Google Scholar
• Timoptic® Sterile Ophthalmic Solution Prescription Information. Merck & Co., Inc.; September 2005
   Google Scholar
• Hiratani H, Alvarez-Lorenzo C. Timolol uptake and release by imprinted soft contact lenses made of N,N-diethylacrylamide and methacrylic acid. J Control Release 2002;83(2):223-30
   PubMed Web of Science ®Google Scholar
• Hiratani H, Alvarez-Lorenzo C. The nature of backbone monomer determines the performance of imprinted soft contact lenses as timolol drug delivery systems. Biomaterials 2004;25(6):1105-13
   PubMed Web of Science ®Google Scholar
• Hiratani H, Mizutani Y, Alvarez-Lorenzo C. Controlling drug release from imprinted hydrogels by modifying the characteristics of the imprinted cavities. Macromol Biosci 2005;5(8):728-33
   PubMed Web of Science ®Google Scholar
• Alvarez-Lorenzo C, Yanez F, Barreiro-Iglesias R, Concheiro A. Imprinted soft contact lenses as norfloxacin delivery systems. J Control Release 2006;113:236-44
   PubMed Web of Science ®Google Scholar
• Venkatesh S, Sizemore S, Zhang J, Byrne M. Therapeutic contact releases: a biomimetic approach towards tailored ophthalmic extended delivery. Polym Mater Sci Eng Preprints 2006;94:766-7
   Google Scholar
• Venkatesh S, Sizemore S, Byrne M. Biomimetic hydrogels for enhanced loading and extended release of ocular therapeutics. Biomaterials 2007;28:717-24
   PubMed Web of Science ®Google Scholar
• Meot-Ner M. The ionic hydrogen bond. Chem Rev 2005;105:213-84
   PubMed Web of Science ®Google Scholar
• Lodish H, Berk A, Zipursky L, Molecular cell biology. Section 2.2. Noncovalent Bonds. W.H. Freeman and Co, New York; 2000
   Google Scholar
• Venkatesh V, Saha J, Pass S, Byrne M. Transport and structural analysis of molecularly imprinted hydrogels for controlled drug delivery. Eur J Pharm Biopharm 2008;69:852-60
   PubMed Web of Science ®Google Scholar
• Zaditor Prescribing Information, Novartis Ophthalmics, 24 March 2006
   Google Scholar
• Zaditor Website. Available from: http://www.zaditor.com/info/about/ zaditor-eye-drops.jsp [Accessed 1 February 2010]
   Google Scholar
• Warner JO, Kaliner MA, Crisci CD, Allergy practice worldwide: a report by the World Allergy Organization Specialty and Training Council. Int Arch Allergy Immunol 2006;139(2):166-74
   PubMed Web of Science ®Google Scholar
• Ali M, Horikawa S, Venkatesh S, Zero-order therapeutic release from imprinted hydrogel contact lenses within in-vitro physiological ocular tear flow. J Control Release 2007;124:154-62
   PubMed Web of Science ®Google Scholar
• Ali M. Therapeutic contact lenses for comfort molecules, Master's Thesis. Auburn University; 2007
   Google Scholar
• Ali M, Byrne M. Controlled release of high molecular weight hyaluronic acid from molecularly imprinted hydrogel contact lenses. Pharm Res 2009;26(3):714-26
   PubMed Web of Science ®Google Scholar
• Vaughan A, Zhang J, Byrne M. Enhancing therapeutic loading and delaying transport via molecular imprinting and living/controlled polymerization. AICHE J 2010;56(1):268-79
   Web of Science ®Google Scholar
• Gomes J, Amankwah R, Powell-Richards A, Dua H. Sodium hyaluronate (Hyaluronic Acid) promotes migration of human corneal epithelial cells in vitro. Br J Ophthalmol 2004;88:821-5
   PubMed Web of Science ®Google Scholar
• Hiratani H, Fujiwara A, Tamiya Y, Alvarez-Lorenzo C. Ocular release of timolol from molecularly imprinted soft contact lenses. Biomaterials 2005;26(11):1293-8
   PubMed Web of Science ®Google Scholar
• Morgan P, Woods C, Tranoudis I, International contact lens prescribing in 2009. Cont Lens Spectr 2010;53:30-5
   Google Scholar
• Prausnitz M, Noonan J. Permeability of cornea, sclera, and conjuctiva: a literature analysis for drug delivery to the eye. J Pharm Sci 1998;87(12):1479-88
   PubMed Web of Science ®Google Scholar
• Drug facts and comparisions. J.B. Lippincott Co, St Louis, Mo; 1991
   Google Scholar
• Drug evaluations subscription. American Medical Association; Spring, Chicago, Ill; 1990
   Google Scholar